ÍøºìºÚÁÏ

Skip to main content

William T Donahoo, MD, FTOS

Endocrinologist (Diabetes & Hormones Specialist)

Photo of William T Donahoo

Research at a glance

Top areas of exploration

  • Diabetes Mellitus, Type 2 , 26 publications
  • Obesity , 21 publications
  • Hypoglycemic Agents , 15 publications
  • Blood Glucose , 12 publications

Research activity

94 publications

3,116 citations

Why is this important?

My publications

94 publications

2022

Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing.

Drug safety

•

2021

Comparing cardiovascular benefits between GLP-1 receptor agonists and SGLT2 inhibitors as an add-on to metformin among patients with type 2 diabetes: A retrospective cohort study.

Journal of diabetes and its complications

•

2021

COVID-19 vaccines are effective in people with obesity: A position statement from The Obesity Society.

Obesity (Silver Spring, Md.)

•

2021

Dietary supplements and alternative therapies for obesity: A Perspective from The Obesity Society's Clinical Committee.

Obesity (Silver Spring, Md.)

•

2020

Acceptance-based therapy: the potential to augment behavioral interventions in the treatment of type 2 diabetes.

Nutrition & diabetes

•